Abstract

Public Health Relevance

The Emory VTEU will participate in DMID 20-0034, a phase 1 trial to evaluate the safety, immunogenicity, and reactogenicity of heterologous and homologous Chimpanzee Adenovirus and self-amplifying mRNA prime-boost prophylactic vaccines against SARS-CoV-2 in healthy adults. 1

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project with Complex Structure Cooperative Agreement (UM1)
Project #
3UM1AI148576-02S1
Application #
10358952
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Gill, Ranjodh Sunny
Project Start
2021-03-17
Project End
2026-11-30
Budget Start
2021-03-17
Budget End
2021-11-30
Support Year
2
Fiscal Year
2021
Total Cost
Indirect Cost

  Institution

Name
Emory University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322